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Summary
Adipose tissue is an important metabolic organ that integrates a
wide array of homeostatic processes and is crucial for whole-
body insulin sensitivity and energy metabolism. Brown adipose
tissue (BAT) is a key thermogenic tissue with a well-established
role in energy expenditure. BAT dissipates energy and protects
against both hypothermia and obesity. Thus, BAT stimulation
therapy is a rational strategy for the looming pandemic of
obesity, whose consequences and comorbidities have a huge
impact on the aged. Shc-deficient mice (ShcKO) were previously
shown to be lean, insulin sensitive, and resistant to high-fat diet
and obesity. We investigated the contribution of BAT to this
phenotype. Insulin-dependent BAT glucose uptake was higher in
ShcKO mice. Primary ShcKO BAT cells exhibited increased mito-
chondrial respiration; increased expression of several mitochon-
drial and lipid-oxidative enzymes was observed in ShcKO BAT.
Levels of brown fat-specific markers of differentiation, UCP1,
PRDM16, ELOVL3, and Cox8b, were higher in ShcKO BAT. In vitro,
Shc knockdown in BAT cell line increased insulin sensitivity and
metabolic activity. In vivo, pharmacological stimulation of ShcKO
BAT resulted in higher energy expenditure. Conversely, pharma-
cological inhibition of BAT abolished the improved metabolic
parameters, that is the increased insulin sensitivity and glucose
tolerance of ShcKOmice. Similarly, in vitro Shc knockdown in BAT
cell lines increased their expression of UCP1 and metabolic
activity. These data suggest increased BAT activity significantly
contributes to the improved metabolic phenotype of ShcKO mice.
Key words: brown adipose; brown adipose tissue; energy
expenditure; healthy aging; insulin; Shc.
Introduction
Obesity is epidemic in the United States; 34% of adults suffer from
obesity. A major consequence is type II diabetes, which is also common
in the U.S., and 27% of adults over 65 suffer from this problem. The
consequences and comorbidities of obesity and diabetes have a massive
negative impact on the aged, including increased risk for cardiovascular
disease, cancer, and stroke (Ramirez-Lassepas, 1998; Wilson & Kannel,
2002; Whitmer et al., 2008; Yosefy, 2008; Penninx et al., 2009; Sakurai
et al., 2010). Thus, strategies to combat obesity and diabetes are
urgently needed and could have a major beneficial impact on the aging
population of all developed counties.
Brown fat stimulation as an anti-obesity strategy lagged for several
years, because it was thought that brown fat was developmentally
eliminated after infancy in humans. More recently, it was shown that
adult humans retain differentiated brown adipose tissue depots, (Cypess
et al., 2009; Virtanen et al., 2009) fostering renewed enthusiasm that
brown fat activity could be stimulated in adult humans as an anti-obesity
therapy.
Brown adipose tissue generates heat via mitochondrial uncoupling
(Farmer, 2008) and is recognized for its anti-obesity properties: more
active brown fat in humans is associated with good health, whereas less
active brown fat is associated with adiposity and insulin resistance (van
Marken Lichtenbelt, 2011; Vijgen et al., 2011; Cannon & Nedergaard,
2012). Also, rodents with higher amounts of BAT gain less weight and
are protected from diabetes (Xue et al., 2007), as are rodents that are
pharmacologically stimulated for transdifferentiation of WAT depots into
brown fat (Ghorbani & Himms-Hagen, 1997).
ShcKO mice were proposed as a model for longevity and healthy
aging (Migliaccio et al., 1999) over 15 years ago, and they are lean,
insulin sensitive, glucose tolerant (Berniakovich et al., 2008; Ranieri
et al., 2010; Tomilov et al., 2011), and stress-resistant (Napoli et al.,
2003; Camici et al., 2007; Menini et al., 2007; Martin-Padura et al.,
2008). While ShcKO mice have deletion of p66Shc, they also exhibit a
significant reduction of p52/46Shc isoforms in insulin-responsive tissues
(Tomilov et al., 2011). As Shc has been implicated in adipocyte
differentiation (Laurino & Cordera, 1998; Boney et al., 2001; Woldt
et al., 2011), we investigated effects of Shc reduction on brown adipose
properties in ShcKO mice.
Results
BAT is more active in ShcKO than in control mice
Shc functions in vivo and in vitro as inhibitor of metabolic insulin signaling,
and thus, ShcKO mice exhibit improved insulin sensitivity in peripheral
tissues and improved systemic glucose tolerance (Tomilov et al., 2011).
To determine which tissues contribute to metabolic phenotype of ShcKO
mice, we performed a kinetic measurement of glucose uptake in vivo
using positron emission/computer tomography (PET/CT). Mice were
challenged with insulin in the pseudofed (i.e. pre-injected with glucose)
(Fig. 1a–f) state. In the pseudofed state, radiotracer uptake by interscap-
ular BAT and gastrocnemius muscle was obviously and significantly higher
in ShcKO mice compared with controls (Fig. 1a,b). PET intensities from
liver, muscles (gastrocnemius and quadriceps femoris group of muscles),
epididymal fat, kidneys, heart and BAT tissuewere plotted as a function of
time and analyzed. Uptake of FDG was strongly insulin-dependent;
tissues with the largest insulin responsewere BAT, liver, muscle, and heart
(Figs 1c,d and S1), which had faster radiotracer uptake kinetics in ShcKO
than controls. Much lower FDG accumulation was observed in WAT
before or after insulin stimulation (data not shown). Difference between
ShcKO and control mice was significant for only BAT (Fig. 1e), muscles
(Fig. 1f), heart, and liver (Fig. S1).
Correspondence
Gino Cortopassi, Department of Molecular Biosciences, 1089 Veterinary Dr., 3007
VM3B, Davis, CA 95616, USA. Tel.: +(530) 754 9665; fax: +(530) 752 4698;
e-mail: gcortopassi@ucdavis.edu
Accepted for publication 5 August 2014
ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
1049
Aging Cell (2014) 13, pp1049–1058 Doi: 10.1111/acel.12267
Ag
in
g 
Ce
ll
(a) (b)
(c) (d)
(f)(e)
(g) (h) (i)
Fig. 1 (a, b) Sagittal and axial PET/CT images of pseudofed mice through brown adipose tissue (BAT) and gastrocnemius muscle, shown by arrows. (c, d) PET intensities were
normalized to total positron emissions for each mouse and plotted against time, traces for BAT and muscle are presented. (e, f) bars are means and SE of area under the
curve (AUC) for BAT and muscle, P-values were generated with ANOVA, n = 4. (g, h, i) Fasted mice were stimulated with insulin. Traces of the [18F]FDG uptake by BAT,
muscles and heart are shown. Reduction of Shc expression in ShcKO BAT is shown on Western blot, *P < 0.1, **P < 0.05.
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Endpoint bio-distribution (EPBD) measurements also confirmed an
increased FDG uptake only in interscapular BAT. In EPDB, mice were
analyzed for radiotracer accumulation in 15 dissected tissues: muscles
(three different groups), liver, kidneys, interscapular BAT, WAT (epidid-
ymal, visceral, perirenal, and subcutaneous) skin, bone marrow, urine,
small intestine, and brain by scintillation counting, revealing similar
trends as in the PET/CT study; however, only ShcKO BAT showed a
significant increase (P = 1.9E-02) in insulin-dependent FDG uptake
compared with controls (Fig. 1j). Thus, by PET-CT pseudofed analysis
and also EPBD analysis, there is a strong and significant increase in BAT
metabolic activity.
In the fasted state, there was no difference in insulin-dependent
FDG uptake by any tissues (Fig. 1g–i). However, ShcKO BAT accumu-
lated 9.88%  1.3 of total FDG, whereas control BAT accumulated
only 6.39%  1.2. Thus, ShcKO BAT was accumulating about 1.5-
fold more radiotracer than controls although not statistically
significant (P = 9.03E-2) with four animals per group and under
alpha 5%.
ShcKO BAT is more metabolically active ex vivo than controls
We excised interscapular BAT, dissociated the cells, and measured their
mitochondrial physiology on the Seahorse. Primary ShcKO BAT cells had
three times higher basal mitochondrial O2 consumption rate (OCR) than
controls, suggesting an increased flux through glycolysis and the TCA
cycle in ShcKO BAT. Oligomycin-inhibited OCR was 3.9  2.67 times
higher than controls, attributable to increased uncoupling (Nicholls
et al., 2010). FCCP-stimulated respiration, which reveals the maximal
respiratory capacity, of ShcKO BAT was also higher than controls
(Fig. 2a,b).
The proton production rate (PPR) is a measure of glycolytic activity
(Nicholls et al., 2010). Primary BAT cells were ‘fasted’ and then given
glucose, to mimic the fasted-to-fed transition. At exposure to glucose,
PPR was gradually and significantly increased in both ShcKO and control
brown adipocytes; however, the rate was much faster in ShcKO brown
adipocytes (Fig. 2c,d).
ShcKO mice have increased expression of major metabolic
enzymes in BAT
We measured the expression of several important metabolic enzymes
in BAT, liver and muscles of ShcKO and controls, and in shRNA, Shc
knockdown differentiated mouse brown fat cell line (BATCL). Results
are presented in Table S1. The most relevant blots are presented in
Figs 3a (BAT) and S2a (muscles) along with densitometry and
statistical analysis, in Figs 3b–e, and S2b. Full gel images for ShcKO
and control BAT Western blots are on Fig. S3. Only ShcKO BAT
exhibited an increase in UCP1 and UCP3 levels. Moreover, fifteen
metabolic enzymes were significantly upregulated only in BAT of
ShcKO, among them such important enzymes governing entrance to
glycolysis and flux to mitochondria: HK, GCK, and PDH. Phosphor-
ylation status of FoxO3a was increased (Table S1), and expression of
PDK4 (a repressor of mitochondrial PDH complex) was decreased.
Expression of several enzymes of the beta-oxidation cascade were
increased in ShcKO BAT, including CPT2, ACADVL, MCAD, ACAA2,
and ETFA (Fig. 3a,c, Table S1). These results indicate that glycolysis,
and mitochondrial pyruvate, and fat oxidation are increased in ShcKO
BAT. By contrast, there was no consistent upregulation of metabolic
enzymes in muscle or liver of ShcKO mice. There was no significant
change in VDAC (Figs 3 and S2, Table S1) or mtDNA/nuclear DNA
ratio (data not shown) in any tissue.
We tested whether white–brown transdifferentiation ‘browning’ of
other white fat depots occurs in ShcKO mice by quantifying BAT-
differentiation markers and UCP1 expression in WAT, liver, and muscles,
but did not find any sign of increased BAT-like differentiation in ‘non-
BAT’ tissues. By contrast, expression of BAT-differentiation-specific
markers was higher in ShcKO BAT than CTL BAT (see 2 paragraphs
below).
ShcKO BAT consists of smaller cells
At the level of cellular morphology, there was a significant increase in
number of smaller brown adipocytes (P < 0.05), and a significant
(a) (b)
(c) (d)
Fig. 2 (a, b) Standard bioenergetic
profiling traces and bars of O2 consumption
rate (OCR) of ShcKO and control mice
brown adipose tissue (BAT) cells cultivated
in 25 mM glucose and 20% FBS, regiments
are indicated, P-values were generated by
AUC ANOVA n = 8. (c) traces of GLUCOX
assay, BAT cells were ‘fasted’ in 2.5 mM
glucose for 16 h. Rates 1–4 are basal
proton production rate (PPR). Media was
supplemented with 25 mM glucose as
indicated, and PPR was recorded for
additional 8 cycles. (d) Bars are means and
SD of PPR, n = 8, and P-values were
generated by AUC ANOVA. Two–three
mice were used per day in three
independent experiments, results were
grouped by genotype; technical replication
was 5, *P < 0.1, **P < 0.05.
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decrease in the number of larger brown adipocytes (P < 0.05) in ShcKO
BAT than controls (Fig. 4a); statistics used are described in figure legend
and Methods. Additionally, lipid droplets were smaller in ShcKO BAT
(Fig. 4b), and this is consistent with Oil Red O staining shown on Fig. S4,
in which, Shc was silenced in mouse brown adipocyte cell line BATCL,
and cells were differentiated into a mature adipocytes. Though there
was a reduction in cell size of ShcKO BAT, there was no reduction in total
BAT mass (Fig. 4c). At 18 months of age, all tissues were analyzed for
cellular morphology by a very experienced laboratory animal pathologist.
The only tissue with altered cell morphology identified by the pathologist
was brown fat.
The BAT-specific markers UCP1, BMP7, Prdm16, PGC1a, ELOVL3, and
Cox8b are diagnostic for differentiated BAT tissue (Ahfeldt et al., 2012).
There was no increase of BAT markers expression in any depot of ShcKO
WAT; that is, no increased transdifferentiation of white adipocytes into
brown was observed (data not shown). However, in ShcKO BAT,
expression of four out of six markers of differentiated brown adipocytes
was increased: UCP1, Prdm16, BMP7, and ELOVL3, P = 1.8E-02, 1.1E-03,
3.0E-02, and 2.2E-02, respectively (Fig. 4d).
Inhibition of BAT abolishes the improved ITT/GTT of ShcKO
mice
ShcKO mice have been shown to be more insulin sensitive and glucose
tolerant than controls under standard conditions by three groups
(Berniakovich et al., 2008; Ranieri et al., 2010; Tomilov et al., 2011)
Fig. 5a,b. However, when the mice were pre-injected with an alpha-
adrenergic BAT-specific inhibitor SR5930A (Ootsuka et al., 2011), the
difference between the mutant and control mice was abolished (Fig. 5c,
d). Similar results were observed with Nembutal, which is less specific for
inhibition of brown fat, but is known to suppress brown fat sympathetic
innervation (Shimokawa et al., 1998).
ShcKO mice have increased epinephrine-induced energy
expenditure that is abolished by increased housing
temperature
Control and ShcKO mice were acclimated to either 21 °C or 28 °C
(thermoneutrality) for 1 week and stimulated with epinephrine during
(a)
(b)
(c)
(d) (e)
Fig. 3 (a) Representative Western blots are
presented. Mice were kept in a
conventional animal facility, fasted for 6 h
and anesthetized with Nembutal
100 mg kg1, the brown adipose tissue
(BAT) tissue was extracted and Western-
analyzed with indicated antibody. Signals
were corrected by tubulin and presented as
% of control, bars are means and SD. (b),
expression of enzymes related to glycolysis,
n = 5; (c) beta-oxidation, n = 5, (d) Shc
isoforms, n = 20; (e) other energy
metabolism related; P-values of ShcKO
versus control were determined by two-
tailed t-test, *P < 0.1, **P < 0.05.
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indirect calorimetry measurement. Shortly after the BAT stimulation
with epinephrine, the energy expenditure (EE) increased and stabilized
at a new higher level. When mice were acclimated to 21 °C (Fig. 5e,
f), the basal EE was similar (P = 2.2E-01) between ShcKO 3.8E-
4  1.7E-5 kJ per (min*g) and control 3.5E-4  1.3E-5 kJ per
(min*g); whereas epinephrine-induced EE was 5.1E-4  2.5E-5 kJ
per (min*g) for control and 6.9E-4  4.1E-5 kJ per (min*g) for
ShcKO (P = 2.0E-05). At 28 °C, there was no difference between
genotypes (data not shown).
IL-6 is involved in BAT-mediated whole-body energy metabolism and
improvement of ITT/GTT after BAT transplantation (Stanford et al.,
2013). We measured but did not find a significant difference between
ShcKO and control mice IL-6 levels, Fig. S5.
Shc effects on BAT are cell autonomous
To test whether Shc effects are a cell autonomous, we generated brown
fat pre-adipocytes with a stable knockdown of Shc and differentiated
them into mature brown adipocytes. shShc knockdowns had decreased
Shc expression (Fig. 6a), and insulin-mediated inhibitory phosphorylation
of FoxO3a was increased. We analyzed the expression of 40 metabolic
enzymes (Table S1). The expression and activity status of PDH (Fig. 6b–d)
was increased. There was a marked increase of UCP1 expression, (UCP1
is the main mitochondrial uncoupling protein) and increased ETFA
expression (beta-oxidation enzyme) was observed. Just as in ShcKO BAT
tissue, shShc BATCL showed threefold increased respiration on 25 mM
glucose, and an increased respiratory capacity compared with shControl
(a)
(b)
(c)
(d)Fig. 4 (a) Bars are % of adipocytes falling
in indicated size distribution, P-values were
calculated by nested random effect model,
n = 5, technical replication also 5. (b)
Representative image of control and ShcKO
brown adipose tissue (BAT) sections at
2509. (c) Bars are means and SD of ShcKO
and control interscapular BAT weights
expressed as % of body weight, n = 6. (d)
Mice were housed at 21 °C, interscapular
BAT was extracted and expression of
differentiated BAT markers was measured
with Q-RT–PCR. Bars are means and SD,
values are expressed as % of control, n = 4,
technical replication 3, and P-values
generated by One Way ANOVA followed by
Scheffe’s post hoc analysis, *P < 0.1,
**P < 0.05.
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(Fig. 6e). ‘Fat-fueled’ (palmitate/BSA) shShc BATCL also consumed more
oxygen than shControls (Fig. 6f). Thus, inhibition of Shc increased
expression of metabolic enzymes in the mouse brown fat cell line BATCL
in vitro. Once differentiated, the shShc BATCL showed increased
expression of UCP1, metabolic enzymes, and increased metabolic
activity on both glucose and lipid substrates. Similarly, increased oxygen
consumption after p52/46Shc knockdown was observed in mouse liver
cells FL83B, mouse muscle cells C2C12, and HeLa cells by two different
methods: BD Biosensor Oxygen Detector plates and Seahorse XF-24
extracellular flux analyzer. By contrast, Shc overexpression suppressed
metabolic activity of the cell lines (data not shown). No increase in
metabolic activity of cells was found, when only p66Shc was knocked
down. Thus, Shc effects on BAT metabolism are consistent with cell-
autonomous idea; however, it appears that p52/46 Shc reduction is the
major contributor to the phenotype.
Discussion
ShcKO mice as a model of healthy aging
The p66ShcKO mouse has been used since 1999 as a model of healthy
aging and longevity; originally its beneficial traits were attributed to redox
properties of p66Shc (Migliaccio et al., 1999). Shc-depleted (ShcKO) mice
resist obesity on chow diets and on high-fat diets and are more insulin
sensitive and glucose tolerant at young and old age (Berniakovich et al.,
2008; Ranieri et al., 2010; Tomilov et al., 2011). Thus, Shc mice are a
model for anti-obesity and antidiabetesmechanisms and to the extent that
these decline with age, ‘healthy aging’. ShcKO mice also resist multiple
stresses and injury, including ischemia reperfusion injury.
Recently, we showed that resistance to high-fat diet, increased
insulin sensitivity and glucose tolerance of these mice are results of
changes in expression of major Shc isoforms: p52 and p46Shc rather
than p66Shc deletion. We compared two different p66Shc knockouts
made in slightly different ways by the T. Prolla group and the PG Pelicci
group. The p66Shc mouse made by the Prolla group has precise
deletion of p66Shc only, this mouse has no health benefits, no
increased insulin sensitivity and glucose control, and no obesity
resistance (Tomilov et al., 2011). By contrast, in the mouse made by
the Pelicci group, perhaps as a result of the residual unexcised neomycin
cassette in addition to the p66Shc deletion, there is decreased
expression of p52/p46 in insulin-responsive tissues and increased
expression of p46 in WAT (Fig. S6). Comparison of Pellici ShcKO to
T. Prolla generated p66ShcKO rules out the p66Shc isoform, and thus,
the beneficial health effects of Shc depletion are the result of p52/46
depletion in ShcKO mice rather than p66Shc deletion. We demon-
strated earlier, that p52/p46 Shc functions as a repressor of metabolic
insulin signaling and that in animals, tissues, and cells p52/p46 Shc
depletion stimulates insulin signaling (Tomilov et al., 2011). Further-
more, p52:p46:p66 ratios are 100:50:1 in tissues. Also, depletion of
p66Shc in cells has no metabolic consequences, whereas p52/46
depletion in cells causes increased insulin sensitivity and mitochondrial
activation. Thus, it is the decrease in the major Shc isoforms p52/p46,
rather than deletion of the minor Shc isoform, which drives both animal
adiposity and insulin sensitivity phenotypes, and cellular mitochondrial
and insulin sensitivity phenotypes.
To further specify the mechanism of reduced adiposity of ShcKO
mice, we tested the insulin sensitivity of ShcKO WAT and found it to be
less sensitive, providing one possible mechanism for reduced adiposity
(Tomilov et al., 2011). However, ShcKO mice are overall more insulin
sensitive at the whole-body level, so we carried out PET/CT experiments
to determine which tissues were specifically contributing to the insulin
sensitivity and thus identified the BAT as a major contributor.
(a)
(b)
(c)
(d)
(f)
(e)
Fig. 5 (a) GTT, (b) ITT of ShcKO and controls; (c) GTT, (d) ITT, mice were pre-injected with SR5930, n = 15. (e) Bars are means and SE of basal and epinephrine-induced
energy expenditure (EE) of ShcKO and control mice housed at 21 °C, n = 9. (f) Traces are representative epinephrine-induced EE curves of control and ShcKO mice as
indicated. P-values were generated by one way ANOVA followed by Scheffe’s post hoc planned comparison, *P < 0.1, **P < 0.05 for ShcKO versus control or indicated as
face values.
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(a) (b)
(c)
(d)
(f)(e)
(g)
Fig. 6 (a) differentiated shShc and shControl brown fat cell line (BATCL) stimulated with insulin andWesterns analyzed with indicated antibody. (b, c, d) bars are densitometry
means and standard deviations of PDH expression normalized to tubulin, total PDH, phospho PDH (P-PDH), and ratio PDH/P-PDH, respectively, P-values were from two-tailed t-
test, n = 6. (e, f) OCRs of shControl and shShc BATCL utilizing 25 mM glucose or 0.8 mM palmitate, as indicated, and P-values are determined with AUC ANOVA, n = 10. (g)
Model of regulatory elements for UCP1 expression adopted and modified from (Klein et al., 2000). UCP1 expression is regulated both by G protein-coupled b3-adrenergic
receptors and signals from the insulin receptor. Shc transfers insulin signal to ERK-the inhibitory arm of UCP1 expression. Shc opposes Pi3Ka arm of UCP1 regulation the
stimulatory arm. Thus, Shc reduction makes the inhibitory arm weaker and stimulatory arm stronger, and promotes UCP1 expression*P < 0.1, **P < 0.05.
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Brown fat is an important force for reduced adiposity in
ShcKO mice
As we imaged the consequences of insulin administration in ShcKO
mice, we noticed an especially strong glucose uptake in brown fat
(Fig. 1), the only significant difference among all tissues surveyed in both
fed and fasted state. Thus, BAT appears to be a sink for nutrient excess.
Under pseudofed conditions to mimic fasted/fed transition, muscles
were also more metabolically active and may partially contribute to the
ShcKO. However, there are multiple reasons that muscle is not the major
contributor to the increased insulin sensitivity of ShcKO mice. First,
pharmacological BAT inhibition with two different drugs abrogated the
ShcKO metabolic benefit. Second, thermoneutrality (Fig. 6g), which
decreases the BAT-specific UCP1 expression and BAT activity also
abrogated the ShcKO metabolic benefit. Third, by EPBD of radioactive
glucose uptake, only ShcKO BAT is significantly more active; no other
tissues have significant changes, and under fasted conditions only BAT
showed a difference. Fourth, muscle and liver glycolytic enzyme
expression and activity were not increased, and in fact, some were
decreased under fasting conditions, suggesting that muscle and liver are
not important sinks of glucose in ShcKO mice (Fig. S2, Table S1,
K. Hagopian, A.A. Tomilov, K. Kim, G.A. Cortopassi and J.J. Ramsey
submitted). Fifth, we have carried out extensive pathological analysis of
100 s of ShcKO mice by laboratory animal pathologists at several age
points, and the only recognizable cellular morphological differences
were in BAT.
How does BAT contribute to the metabolic phenotype of
ShcKO mice
Once focused on BAT, we find several mechanisms operate to activate
them in ShcKO mice. First, BAT is more ‘brown’, that is more
differentiated, with higher expression of UCP1 that uncouples mito-
chondria, making them more ‘leaky’, expending more energy (Bernia-
kovich et al., 2008), and multiple differentiation markers are elevated in
ShcKO BAT. Second, as a consequence of this gene expression and
mitochondrial uncoupling, there is increased mitochondrial physiological
oxidative capacity in ShcKO brown adipose cells ex vivo (Fig. 2). Third,
this increased activity, demonstrated physiologically, is supported by
increased expression of lypolytic and mitochondrial-limiting enzymes
(PDH, ETFA, and ACAA2) (Fig. 3). Fourth, Shc knockdown in BAT cell
lines (Fig. 6) increases PDH, ETFA, ACAA2, and UCP1, showing a Shc-
specific effect on mitochondrial activation in this cell type.
Relevance and relationship of mouse BAT to the Human
perspective
Although for many years, BAT was not thought to exist in adults at all,
recently, multiple brown fat depots have been identified (cervical,
clavicular, paravertebral, mediastinal, para-aortic, and suprarenal), and
demonstrated as active ‘sinks’ for glucose in vivo and to be important for
obesity resistance and insulin sensitivity (Cypess et al., 2009; Virtanen
et al., 2009; Farmer, 2008; van Marken Lichtenbelt, 2011; Muralidhara
& Muralidhara, 2011; Virtanen & Nuutila, 2011; Cannon & Nedergaard,
2012). The data presented here suggest that depletion of p46/p52 Shc
increases differentiation, enzyme activity, and mitochondrial activity of
BAT, which increases insulin sensitivity and glucose tolerance in mice.
Thus, genetic or pharmacological Shc inhibition may be a viable strategy
to increase brown fat activity in pursuit of anti-obesity or antidiabetic
goals. This strategy could have impact in the U.S., and other developed
countries in which obesity and diabetes and their comorbid conse-
quences are major heath issues for the aged.
Conclusions
1 In ShcKO mice brown fat is hyperactivated, contributes to glucose
disposal and likely contributes to the healthy phenotype;
2 These effects may be cell autonomous and involve signaling roles of
major Shc proteins in insulin signaling;
3 This work supports the notion that targeting brown fat by Shc
inhibition may represent a strategy to prevent human obesity and its
detrimental consequences on age-related disease.
Experimental procedures
Animals
ShcKO are originally described in (Migliaccio et al., 1999). Mice were
kept pathogen-free throughout the study. All experimental procedures
were approved by the Institutional Animal Care and Use Committee
(IACUC) and were performed in compliance with local, state, and federal
regulations. Diet was LM-485 (Teklad 7012) with nutrient composition:
protein = 19.9%, carbohydrates = 53.7%, fat = 5.7%. The source of
lipid was soybean oil, protein – soybean meal, energy source – ground
oats.
Materials and antibodies
Media DMEM and F12-B, minimal essential medium amino acids,
penicillin/streptomycin, fetal bovine serum were purchased from GIBCO
(Grand Island, NY, USA). Insulin and specific brown fat inhibitor
SR59230A were from Sigma (St. Louis, MO, USA). Antibodies were
from Cell Signaling Inc. (Danvers, MA, USA) except: rabbit anti-Shc and
anti-Cyt-C antibody were from BD Biosciences (San Diego, CA, USA);
rabbit antiphospho-PDH, PCX, UCP3, goat anti-GCKR, mouse anti-
ACADVL were from Novus Biologicals (Littletown, CO, USA); anti-
Tubulin – Sigma; rabbit anti-UCP1 and CPS1, mouse anti-PDH, MCAD,
and ACAA1 were from Abcam Inc. (Cambridge, MA, USA); rabbit anti
CPT2, PFKL, HK were from Epitomics Inc. (Burlingame, CA, USA); rabbit
anti-GCK – from LifeSpan BioScience Inc. (Seattle, WA, USA); goat anti-
PFKM were from GenWay Biotech Inc. (San Diego, CA, USA); goat anti-
UCP2 were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA);
the secondary infrared dye 700 and 800 labeled antibody were from
Li-Cor Biosciences (Lincoln, NE). Trans-Lenti shRNA packaging plasmids,
shShc-GIPZ lentiviral shRNA and Nonsilencing-GIPZ lentiviral shRNAmir
control plasmids were from Thermo Scientific Inc. (Pittsburgh, PA, USA).
PET/CT measurement of glucose uptake in vivo
In pseudofed experiments, mice were injected with 2 mg kg1 of
glucose intraperitoneally 15 min prior to the injection of 18F-FDG. The
mice were anesthetized with a mixture of isoflurane/oxygen and imaged
dynamically using a Focus 120 small animal PET scanner (Siemens
Preclinical Solutions, Knoxville, TN, USA) with a resolution of 1.3 mm.
Five seconds after the start of the acquisition, the animals were
administered ~200 uCi of 18F-FDG (PETNET Pharmaceuticals- Sacra-
mento, CA) in addition to 3 mU g1 of body weight of insulin (when
insulin was used) via tail vein. Anatomical images were taken with a
small animal InveonMM microcomputed tomography (CT) scanner
(Siemens Preclinical Solutions) for coregistration with the PET images
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with corresponding voxel size of 0.097 mm 9 0.097 mm 9 0.097 mm.
PET intensities were exported by INVEON RESEARCH WORKPLACE software
(Siemens, Marburg, Germany).
Western blotting
Proteins were isolated with Cell Lysis Buffer (Cell Signaling Technolo-
gies), resolved by SDS-PAGE, transferred, blocked with Blocking Buffer
(Li-Cor Biosciences), and hybridized with indicated primary and IR-dye
700CW, 800CW secondary antibody.
Insulin and glucose tolerance tests
Mice were fasted for 6 h and given intraperitoneal injection of insulin
(0.2 U kg1). In the glucose tolerance test after 16 h fasting, mice were
given injection of glucose (2 mg kg1); the blood glucose was measured.
Same groups of mice were used in ITT/GTT, but mice were pre-injected
with a specific brown fat inhibitor SR59230A (5 mg kg1) n = 15.
Bioenergetic profiling
Brown adipocytes were isolated as described (Fasshauer et al., 2001),
200 lL per well of cell suspension was plated on 24 well plates
(Seahorse Biosciences, Billerica, MA, USA) and incubated overnight.
Media was changed to unbuffered DMEM, 20% FBS, 200 mM glutamax,
100 mM sodium pyruvate, 25 mM glucose, pH 7.4. Cells were pre-
equilibrated for 1 h; OCR and PPR were recorded with Seahorse XF-24.
Regimens: Oligomycin – 1 lM, FCCP – 12.5 lM, Rotenone – 0.1 lM,
Antimycin A – 1 lM. Total protein in each well was measured. Values
were expressed as pmoles per [min*lg (protein)].
Brown fat cell line (Fasshauer et al., 2001) was stably transfected with
lentiviral shShc and shNon-silencing-GIPZ shRNA. Stable transfected cells
were selected with FACS for GFP. Fifty thousand cells per well were
seeded on Seahorse plate and differentiated in differentiation media
containing 20% FBS, 20 nM insulin and 1 nM triiodothyronine for 48 h,
than were supplemented with 0.5 mM dexamethasone, 0.5 mM isobu-
tylmethylxanthine, and 0.125 mM indomethacin for 48 h, and returned
to differentiation media. At day 8 cells were differentiated. Unbuffered
DMEM containing 10% FBS was used for glucose driven OCR measure-
ments; KHB-for palmitate driven OCR. KHB: 111 mM NaCl, 4.7 mM KCl,
2 mM MgSO4, 1.2 mM Na2HPO4, 0.5 mM carnitine, 1% FBS, pH 7.4.
Indirect respiration calorimetry
Energy expenditure was measured in 0.8 L chambers with catheter for
subcutaneous injections. Animals were acclimated to 21 °C or 28 °C for
1 week, anesthetized with 100 mg kg1 of Nembutal, catheterized and
adapted to the chambers for 20 min, epinephrinewas 1 mg kg1. Airwas
drawn at 250 mL min1. Oxygen content was measured by O2 analyzer
(FC-10, Sable Systems), and CO2 – by CO2 analyzer (CA-10, Sable
Systems). EE was calculated with Weir equation (Cunningham, 1990):
EE (kJ) ¼ ð16:5 kJ=L VO2Þ þ ð4:63 kJ=L VCO2Þ
Brown adipose tissue adipocytes size distribution was measured using
IMAGEJ software (NIH, Bethesda, MD, USA) on H&E stained five random
100 lm sick sections of BAT from each of five animals of each genotype
in double blinded experiment. Micrographs resolution was 2.826
pixels lm1, 2509.
Primers for Q-RT–PCR were as follows: Cox8b CCCAGCTGGCTA
CCTAAGTG, GAACCATGAAGCCAACGACT, ELOVL3 ATGAACTT
TGGCGTCCATTC, CTTTCTCCTGCCTCCAGATG, PGC1a ATGTGTCGCC
TTCTTGCTCT, CACGACCTGTGTCGAGAAAA, Prdm16 CAGCACGGT
GAAGCCATTC, GCGTGCATCCGCTTGTG, BMP7 CCTGTCCATCTTAGG
GTTGC, GCCTTGTAGGGGTAGGAGAAG, UCP1 GATGGTGAACCCG-
ACAACTT, and CTGAAACTCCGGCTGAGAAG.
Statistical analysis
with SAS 9.4 (SAS Institute, Cary, NC, USA) and EXCEL STATISTICAL DATA
ANALYSIS TOOL package 2007, unless indicated otherwise, was performed
with One Way ANOVA followed by Scheffe’s post hoc planned
comparison test, (*)-P < 0.1, (**)-P < 0.05. For the ShcKO and controls
BAT cell size distribution, we performed nested random-effects analysis
of variance for the data with a nested structure, where five animals were
randomly chosen in each genotype, and then five slides for each animal
were quantified. For uptake of FDG measured at serial time points
postinsulin injection, we utilized the area under the PET counts time
curve as a measure for the aggregate effect over a period of time. AUC
values were calculated using the trapezoidal rule. Then the total AUC
values were compared between groups by ANOVA to test the overall
effects of the Shc deletion on insulin-dependent FDG uptake.
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Fig. S1 (a, c) PET/CT was performed as described. PET intensities were
normalized to total positron emissions for each mouse and plotted against
time; traces for heart and liver are presented. (b, d) bars are means and SE of
AUC, P values were generated with ANOVA, n = 4.
Fig. S2 (a) Representative Western Blots are presented. Mice were kept in a
conventional animal facility, fasted for 6 h and anesthetized with Nembutal
100 mg kg1, the muscle tissue was extracted and Western-analyzed with
indicated antibody. (b) Signals were corrected by tubulin and presented as %
of control, bars are means and SD, n = 5; P-values of ShcKO vs. control were
determined by two tailed t-test, (*)-P < 0.1, (**)-P < 0.05.
Fig. S3 Mice were kept in a conventional animal facility, fasted for 6 h and
anesthetized with Nembutal 100 mg kg1, the BAT tissue was extracted and
Western-analyzed with indicated antibody. C = control, S = ShcKO.
Fig. S4 Fully differentiated shShc and shControl BATCL, as indicated, stained
with Oil Red-O.
Fig. S5 Blood was collected from tail of ShcKO and control mice, 5 month
old. IL6 levels were measured with Mouse IL-6 ELISA Kit (Piercenet, Thermo
Scientific) Cat#: EM2IL6. Bars are mean and SD, n = 3.
Fig. S6 (a) Liver, muscles, pancreatic islands, interscapulat BAT, heart,
epididymal WAT, visceral WAT, perirenal WAT, spleen, mouse embryonic
fibroblasts (MEFs), macrophages, brains, lungs from ShcKO and control mice
were Western analyzed with anti-Shc antibody. Table shows relative
expression of Shc isoforms in ShcKO mice to control. n > 5, P < 0.05, fold
change (FC)>2.0. (b) Representative Western Blots of Shc isoforms expression
in ShcKO and control mice tissues, as indicated.
Table S1 BAT, muscle, liver from ShcKO and control mice, and shShcBATCL,
and shControlBATCL were western analyzed with indicated antibody.
Direction of ShcKO/control fold change is indicated in the table. P < 0.05,
n = 5. For BATCL n = 6. P-values were from two tailed t-test.
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